Biofeedback for treatment of chronic idiopathic constipation in adults

S Woodward, C Norton… - Cochrane Database of …, 2014 - cochranelibrary.com
Background Biofeedback therapy has been used to treat the symptoms of people with
chronic constipation referred to specialist services within secondary and tertiary care …

Biofeedback therapy for constipation in adults

SSC Rao - Best practice & research Clinical gastroenterology, 2011 - Elsevier
Dyssynergic defecation is common and affects up to one half of patients with chronic
constipation. This acquired behavioural problem is due to the inability to coordinate the …

Intraluminal pressure patterns in the human colon assessed by high-resolution manometry

JH Chen, Y Yu, Z Yang, WZ Yu, WL Chen, H Yu… - Scientific reports, 2017 - nature.com
Assessment of colonic motor dysfunction is rarely done because of inadequate methodology
and lack of knowledge about normal motor patterns. Here we report on elucidation of …

S2k-Leitlinie chronische obstipation: definition, pathophysiologie, diagnostik und therapie

V Andresen, P Enck, T Frieling, A Herold… - Zeitschrift für …, 2013 - thieme-connect.com
Chronische Obstipationsbeschwerden zählen mit einer Prävalenz von 5–15% zu den
häufigen Gesundheitsstörungen in Deutschland, wobei die Prävalenz mit dem Alter zunimmt …

Chronic constipation: gastroenterohepatologist's approach

T Milosavljevic, DD Popovic, DD Mijac… - Digestive …, 2022 - karger.com
Background: Constipation is a common problem in gastroenterological practice. The
prevalence of constipation is about 16%. Constipation can be primary or secondary …

Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation

AJ Lembo, JF Johanson, HP Parkman, SS Rao… - Digestive diseases and …, 2011 - Springer
Background Lubiprostone helps relieve constipation in short-term 4-week studies. There are
limited data on long-term pharmacological treatment with lubiprostone for chronic idiopathic …

Randomised clinical trial: macrogol/PEG 3350+ electrolytes versus prucalopride in the treatment of chronic constipation‐a comparison in a controlled environment

R Cinca, D Chera, HJ Gruss… - Alimentary pharmacology …, 2013 - Wiley Online Library
Background Constipation is a common condition for which PEG 3350 is an established
treatment and prucalopride has recently been approved for this indication. Aim To compare …

[HTML][HTML] Biofeedback therapy for dyssynergic defecation

G Chiarioni, S Heymen… - World Journal of …, 2006 - ncbi.nlm.nih.gov
Dyssynergic defecation is one of the most common forms of functional constipation both in
children and adults; it is defined by incomplete evacuation of fecal material from the rectum …

Characteristics of fecal microbiota in different constipation subtypes and association with colon physiology, lifestyle factors, and psychological status

T Yu, Y Ding, D Qian, L Lin… - Therapeutic Advances in …, 2023 - journals.sagepub.com
Background: Patients with chronic constipation (CC) show altered gut microbial composition.
Objectives: To compare the fecal microbiota with different constipation subtypes and to …

Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment

M Corsetti, S Brown, G Chiarioni… - …, 2021 - Wiley Online Library
Background Chronic constipation is a prevalent disorder that affects quality of life of patients
and consumes resources in healthcare systems worldwide. In clinical practice, it is still …